Udg Healthcare PLC (LON:UDG) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as GBX 623.50 ($8.15) and last traded at GBX 626 ($8.18), with a volume of 1153802 shares changing hands. The stock had previously closed at GBX 644.50 ($8.42).
Several equities research analysts have recently weighed in on UDG shares. Liberum Capital reissued a “buy” rating and set a GBX 884 ($11.55) target price on shares of Udg Healthcare in a research report on Monday, June 18th. Peel Hunt reissued a “buy” rating on shares of Udg Healthcare in a research report on Tuesday, July 3rd. Numis Securities reissued a “reduce” rating on shares of Udg Healthcare in a research report on Tuesday, July 3rd. Jefferies Financial Group raised Udg Healthcare to a “buy” rating and cut their target price for the stock from GBX 895 ($11.69) to GBX 890 ($11.63) in a research report on Thursday, August 9th. Finally, Barclays reissued an “equal weight” rating on shares of Udg Healthcare in a research report on Friday, September 28th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of GBX 850.67 ($11.12).
In other news, insider Peter Gray purchased 14,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 19th. The shares were purchased at an average price of GBX 631 ($8.25) per share, for a total transaction of £88,340 ($115,431.86).
Udg Healthcare Company Profile (LON:UDG)
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates through three segments: Ashfield, Sharp, and Aquilant.
Read More: Investing in Dividend Stocks
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.